American Financial Group’s AbbVie ABBV Stock Holding History

American Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-20,000	Closed	-$1.96M	–	114
2020 Q2	$1.96M	Sell	20,000 -150,000	-88%	-$13.2M	0.26%	71
2020 Q1	$13M	Hold	170,000	–	–	1.54%	20
2019 Q4	$15.1M	Hold	170,000	–	–	1.3%	30
2019 Q3	$12.9M	Buy	170,000 +130,000	+325%	+$8.91M	1.05%	34
2019 Q2	$2.91M	Buy	+40,000	New	+$3.14M	0.24%	74
2017 Q3	–	Sell	-220,000	Closed	-$16M	–	106
2017 Q2	$16M	Hold	220,000	–	–	1.52%	25
2017 Q1	$14.3M	Hold	220,000	–	–	1.33%	31
2016 Q4	$13.8M	Hold	220,000	–	–	1.32%	30
2016 Q3	$13.9M	Hold	220,000	–	–	0.99%	30
2016 Q2	$13.6M	Hold	220,000	–	–	1.04%	29
2016 Q1	$12.6M	Hold	220,000	–	–	0.94%	37
2015 Q4	$13M	Buy	220,000 +30,000	+16%	+$1.73M	1%	31
2015 Q3	$10.3M	Buy	+190,000	New	+$12.4M	0.75%	45
2014 Q2	–	Sell	-9,100	Closed	-$468K	–	157
2014 Q1	$468K	Hold	9,100	–	–	0.04%	97
2013 Q4	$481K	Hold	9,100	–	–	0.05%	93
2013 Q3	$407K	Hold	9,100	–	–	0.04%	101
2013 Q2	$376K	Buy	+9,100	New	+$398K	0.03%	107

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

American Financial Group's ABBV Position: Q3 2020 in Review

American Financial Group sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 20,000 shares — an estimated $1.96M sold.

American Financial Group first reported a position in ABBV in Q2 2013 and held it in 17 quarters. The position peaked at $16M in Q2 2017. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

American Financial Group reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
American Financial Group sold 20,000 AbbVie shares in Q3 2020, an estimated $1.96M.
American Financial Group first reported a position in AbbVie in Q2 2013 and held it in 17 quarters.
American Financial Group's AbbVie position peaked at $16M in Q2 2017.
2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on American Financial Group's 13F filing for Q3 2020, filed 9 Nov 2020.